JAZZ PHARMACEUTICALS PLC (JAZZ) Stock Income Statement
NASDAQ:JAZZ - Nasdaq - IE00B4Q5ZN47 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.07B | 3.83B | 3.66B | 3.09B | 2.36B | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 445.71M | 435.58M | 540.50M | 440.80M | 148.90M | |||
| Gross Profit | 3.62B | 3.40B | 3.12B | 2.65B | 2.21B | |||
| Operating Expenses | 2.90B | 2.72B | 3.01B | 2.25B | 1.70B | |||
| Research and Development | 884.00M | 849.66M | 1.03B | 505.70M | 586.60M | |||
| Selling, General, and Administrative Expenses | 1.39B | 1.26B | 1.38B | 1.22B | 854.20M | |||
| Operating Income | 726.63M | 678.38M | 108.90M | 399.30M | 514.20M | |||
| Interest Income/Expense | -246.28M | -280.65M | -307.30M | -283.10M | -97.90M | |||
| Non Recurring Items | -10.00M | -99.80M | -174.40M | -229.00M | -141.20M | |||
| Income Before Taxes | 470.35M | 297.93M | -372.80M | -112.80M | 275.10M | |||
| Income Tax | -91.43M | -119.91M | -158.60M | 216.10M | 33.50M | |||
| Net Income | 560.12M | 414.83M | -224.10M | -329.70M | 238.60M | |||
| EBITDA | 1.39B | 1.32B | 738.40M | 951.80M | 792.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 8.48 | 5.75 | -3.58 | -5.52 | 4.22 | |||
| Non GAAP EPS | 21.19 | 18.32 | 13.13 | 16.23 | 12.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.05% | 88.64% | 85.23% | 85.76% | 93.70% | |||
| Profit Margin | 13.77% | 10.82% | -6.12% | -10.66% | 10.09% | |||
| Operating Profit Margin | 17.86% | 17.69% | 2.98% | 12.90% | 21.75% | |||
All data in USD